Zeidner, J., Jamy, O., Christensen, B., Khan, S., Cicic, D., Kadia, T. (2025). Phase 2 study of SLS009 in combination with azacitidine and venetoclax for relapsed/refractory AML with MDS-related changes (AML-MR) after prior venetoclax treatment. Blood. https://doi.org/10.1182/blood-2025-3423